Renal disease News and Research

RSS

Fenofibrate intervention and event lowering in diabetes

Fenofibrate is the first and only widely available lipid modifying agent to demonstrate significant protection to the eye of patients with type 2 diabetes, reducing the need for laser therapy in a wide spectrum of patients which should decrease the risk of progressive loss of vision.

6 Nov 2007

Early intervention dramatically improves outcomes for new dialysis patients

A program of education, close medical follow-up, and self-empowerment for patients with end-stage renal disease (ESRD) newly starting dialysis, reduces complications and improves outcomes - including significant reductions in mortality and hospitalization rates, reports a study in the November Clinical Journal of the American Society of Nephrology.

19 Oct 2007

HIV linked to increased risk of end-stage renal disease in African-Americans

For African Americans infected with HIV, the risk of end-stage renal disease (ESRD) is six times higher than for whites with HIV - and similar to the ESRD risk associated with diabetes, reports a study in the November Journal of the American Society of Nephrology.

18 Oct 2007

UCLA Medical Center performs its first living donor kidney swap

UCLA Medical Center on Sept. 20 performed its first living donor kidney “swap,” a procedure in which a loved one of a kidney transplant patient who is not compatible as a donor exchanges organs with another incompatible pair under an innovative new paired donation program.

27 Sep 2007

New ESC-ESH guidelines on arterial hypertension

In 2000, 26% (972million) of the adult population worldwide had hypertension and this figure is estimated to rise by 2025 to 1.56billion.

3 Sep 2007

Staggering costs of end-stage renal disease in U.S.

Recent progress in the prevention and treatment of end-stage renal disease (ESRD) in the United States give reason for "cautious optimism," but skyrocketing costs are a major concern, according to a Special Article in the October Journal of the American Society of Nephrology.

12 Aug 2007

Sex hormones play a significant role in the development of diabetic kidney disease

Women have a "female advantage" when it comes to chronic kidney disease. When compared to men, they have fewer and less severe episodes of this disorder throughout most of their lives.

11 Aug 2007

Testosterone replacement therapy for men

For decades, older women have taken hormone replacements to replenish estrogen and progesterone levels lost to aging.

9 Aug 2007

Sex and gender in cardiovascular-renal physiology and pathophysiology

Gender influences the prevalence and progression rate of many renal diseases, such as polycystic kidney disease (PKD).

9 Aug 2007

Changing face of dialysis care in the United States

As medical, economic, and policy trends converge to alter the way dialysis care is organized and financed, protecting the unique relationship between dialysis patients and the kidney specialists who direct their care is a top priority, according to a special feature in the July Journal of the American Society of Nephrology.

17 Jun 2007

The cost-effectiveness of improving diabetes care in U.S. federally-qualified community health centers

The health benefits of a federal diabetes care program are clear, but now researchers say that program upgrades also are economically sound.

28 May 2007

Transforming kidney transplant policy

A new article published in American Journal of Transplantation examines the dilemmas faced in trying to change kidney transplant policy; addressing the need to balance the benefits of immediate transplants with those to be had from waiting for a more suitable match.

18 May 2007

Quality improvement effort pays off in diabetes care

Spending money to improve diabetes care at federally qualified community health centers is a sound investment, according to one of the first studies to examine the clinical and economic impact of quality improvement on diabetes care.

18 May 2007

Rosuvastatin well tolerated by a broad range of patients with dyslipidemia

The safety and tolerability of rosuvastatin were assessed using data from 16,876 patients who received rosuvastatin 5-40 mg in a multinational phase II/III/IIIb/IV program, representing 25,670 patient-years of continuous exposure to rosuvastatin. An integrated database, consisting of 33 trials whose databases were locked up to and including September 16, 2005, was used to examine adverse events and laboratory data.

9 May 2007

Cause of gender differences in high blood pressure and related kidney disease

While men and women both get high blood pressure and related kidney disease, the path to get there is shorter, steeper and just different for men, researchers say.

4 May 2007

Renal transplantation in 1-5 year olds

Garcia, et al reported their experience with renal transplantation in 38 children (40 transplant), ages 1-5 years over a 16 year period.

26 Apr 2007

Anemia treatment for patients with kidney disease can differ by dialysis facility type

Large, for-profit dialysis facilities appear to administer higher than necessary amounts of a medication for treating anemia in patients with kidney disease, compared to nonprofit facilities, according to a study in the April 18 issue of JAMA.

18 Apr 2007

Weight-lifting exercises during dialysis improves muscle mass, strength, quality of life

Performing high-intensity weight-lifting exercise during dialysis sessions brings meaningful improvements in muscle mass, strength, quality of life, and other important health outcomes in patients with end-stage renal disease (ESRD), reports a study in the May Journal of the American Society of Nephrology.

5 Apr 2007

Kidney disease in children: common but treatable

"Kidney disease occurs more often than we think, but it is also more treatable than we used to think, especially when caught early," says Barbara Fivush, M.D., director of nephrology at the Johns Hopkins Children's Center.

8 Mar 2007